Skewed Signaling through the Receptor for Advanced Glycation End-Products Alters the Proinflammatory Profile of Tumor-Associated Macrophages

作者: Armando Rojas , Paulina Araya , Jacqueline Romero , Fernando Delgado-López , Ileana Gonzalez

DOI: 10.1007/S12307-018-0214-4

关键词:

摘要: Tumors are complex tissues composed of variable amounts both non-cellular components (matrix proteins) and a multitude stromal cell types, which under an active cross-talk with tumor cells. Tumor-associated macrophages (TAMs) the major leukocyte population among tumor-infiltrating immune Once they infiltrated into stroma undergo polarized activation, where M1 M2 phenotypes represent two extreme polarization heterogeneity spectrum. It is known that TAMs acquire specific phenotype (M2), oriented toward growth, angiogenesis immune-suppression. A growing body evidences supports presence tuning mechanisms in order to skew or restraint inflammatory response thus forces them function as tumor-promoting The receptor advanced glycation end-products (RAGE) member immunoglobulin protein family surface molecules, being activated by several danger signals signaling promote production many pro-inflammatory molecules. Interestingly, this paradoxically expressed phenotypes. This review addresses how RAGE has been drifted away macrophages, taking advantage abundance ligands at microenvironment, particularly HMGB1, reinforce supportive strategy support growth.

参考文章(117)
Lionel B. Ivashkiv, Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. European Journal of Immunology. ,vol. 41, pp. 2477- 2481 ,(2011) , 10.1002/EJI.201141783
Michael T. Lotze, Kevin J. Tracey, High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Reviews Immunology. ,vol. 5, pp. 331- 342 ,(2005) , 10.1038/NRI1594
Lara Campana, Lidia Bosurgi, Patrizia Rovere-Querini, HMGB1: a two-headed signal regulating tumor progression and immunity Current Opinion in Immunology. ,vol. 20, pp. 518- 523 ,(2008) , 10.1016/J.COI.2008.04.012
Bernard Caillou, Monique Talbot, Urbain Weyemi, Catherine Pioche-Durieu, Abir Al Ghuzlan, Jean Michel Bidart, Salem Chouaib, Martin Schlumberger, Corinne Dupuy, Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0022567
Muhammad M Alam, Luke A O'Neill, None, MicroRNAs and the resolution phase of inflammation in macrophages European Journal of Immunology. ,vol. 41, pp. 2482- 2485 ,(2011) , 10.1002/EJI.201141740
Katrin Berbaum, Kirubakaran Shanmugam, Grant Stuchbury, Florian Wiede, Heiner Körner, Gerald Münch, None, Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine. ,vol. 41, pp. 198- 203 ,(2008) , 10.1016/J.CYTO.2007.11.012
Willscott E. Naugler, Michael Karin, The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer Trends in Molecular Medicine. ,vol. 14, pp. 109- 119 ,(2008) , 10.1016/J.MOLMED.2007.12.007
Michele De Palma, Claire E. Lewis, Macrophage Regulation of Tumor Responses to Anticancer Therapies Cancer Cell. ,vol. 23, pp. 277- 286 ,(2013) , 10.1016/J.CCR.2013.02.013
Seth Rakoff-Nahoum, Ruslan Medzhitov, Toll-like receptors and cancer Nature Reviews Cancer. ,vol. 9, pp. 57- 63 ,(2009) , 10.1038/NRC2541